Literature DB >> 15961237

Further characterization of muscarinic agonist-induced epileptiform bursting activity in immature rat piriform cortex, in vitro.

B J Whalley1, M Postlethwaite, A Constanti.   

Abstract

The characteristics of muscarinic acetylcholine receptor agonist-induced epileptiform bursting seen in immature rat piriform cortex slices in vitro were further investigated using intracellular recording, with particular focus on its postnatal age-dependence (P+14-P+30), pharmacology, site(s) of origin and the likely contribution of the muscarinic acetylcholine receptor agonist-induced post-stimulus slow afterdepolarization and gap junction functionality toward its generation. The muscarinic agonist, oxotremorine-M (10 microM), induced rhythmic bursting only in immature piriform cortex slices; however, paroxysmal depolarizing shift amplitude, burst duration and burst incidence were inversely related to postnatal age. No significant age-dependent changes in neuronal membrane properties or postsynaptic muscarinic responsiveness accounted for this decline. Burst incidence was higher when recorded in anterior and posterior regions of the immature piriform cortex. In adult and immature neurones, oxotremorine-M effects were abolished by M1-, but not M2-muscarinic acetylcholine receptor-selective antagonists. Rostrocaudal lesions, between piriform cortex layers I and II, or layer III and endopiriform nucleus in adult or immature slices did not influence oxotremorine-M effects; however, the slow afterdepolarization in adult (but not immature) lesioned slices was abolished. Gap junction blockers (carbenoxolone or octanol) disrupted muscarinic bursting and diminished the slow afterdepolarization in immature slices, suggesting that gap junction connectivity was important for bursting. Our data show that neural networks within layers II-III function as primary oscillatory circuits for burst initiation in immature rat piriform cortex during persistent muscarinic receptor activation. Furthermore, we propose that muscarinic slow afterdepolarization induction and gap junction communication could contribute towards the increased epileptiform susceptibility of this brain area.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15961237     DOI: 10.1016/j.neuroscience.2005.04.018

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  6 in total

1.  Network burst activity in hippocampal neuronal cultures: the role of synaptic and intrinsic currents.

Authors:  Jyothsna Suresh; Mihailo Radojicic; Lorenzo L Pesce; Anita Bhansali; Janice Wang; Andrew K Tryba; Jeremy D Marks; Wim van Drongelen
Journal:  J Neurophysiol       Date:  2016-03-16       Impact factor: 2.714

2.  Effects of carbenoxolone on heart rhythm, contractility and intracellular calcium in streptozotocin-induced diabetic rat.

Authors:  F C Howarth; M A Qureshi
Journal:  Mol Cell Biochem       Date:  2006-04-01       Impact factor: 3.396

3.  Investigation of the effects of the novel anticonvulsant compound carisbamate (RWJ-333369) on rat piriform cortical neurones in vitro.

Authors:  B J Whalley; G J Stephens; A Constanti
Journal:  Br J Pharmacol       Date:  2009-03       Impact factor: 8.739

4.  Neuromantic - from semi-manual to semi-automatic reconstruction of neuron morphology.

Authors:  Darren R Myatt; Tye Hadlington; Giorgio A Ascoli; Slawomir J Nasuto
Journal:  Front Neuroinform       Date:  2012-03-16       Impact factor: 4.081

Review 5.  The piriform cortex and human focal epilepsy.

Authors:  David N Vaughan; Graeme D Jackson
Journal:  Front Neurol       Date:  2014-12-08       Impact factor: 4.003

6.  Endogenous cholinergic tone modulates spontaneous network level neuronal activity in primary cortical cultures grown on multi-electrode arrays.

Authors:  Mark W Hammond; Dimitris Xydas; Julia H Downes; Giovanna Bucci; Victor Becerra; Kevin Warwick; Andrew Constanti; Slawomir J Nasuto; Benjamin J Whalley
Journal:  BMC Neurosci       Date:  2013-03-26       Impact factor: 3.288

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.